Skip to main content

RHUMBLINE ADVISERS

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1115418 BOSTON, MA

Position in LGND

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$11,340,120
+$613,045 QoQ
Shares Held
56,800
+0.1% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 45.985915492957744.ToString("F0")% Shared 0.ToString("F0")% None 54.01408450704225.ToString("F0")%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. LGND ranks #24 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,340,120 56,800
2025-12-31 $10,727,075 56,736
2025-09-30 $10,526,013 59,422
2025-06-30 $6,764,869 59,508
2025-03-31 $6,040,923 57,456
2024-12-31 $6,369,531 59,445
2024-09-30 $6,007,401 60,020
2024-06-30 $5,167,834 61,332
2024-03-31 $4,404,640 60,255
2023-12-31 $4,251,275 59,525
2023-09-30 $3,423,049 57,127
2023-06-30 $4,001,477 55,499
2023-03-31 $3,901,695 53,041
2022-12-31 $3,386,693 50,699
2022-09-30 $2,605,699 48,507
2022-06-30 $2,662,906 47,844
2022-03-31 $3,229,930 46,027
2021-12-31 $4,336,345 45,003
2021-09-30 $4,016,290 46,211
2021-06-30 $4,142,919 50,622
2021-03-31 $4,328,608 45,515
2020-12-31 $2,841,799 45,806
2020-09-30 $2,722,833 45,790
2020-06-30 $3,815,877 54,688
2020-03-31 $2,830,043 62,384